UAS regulatory sequences drive expression of Syt1 carrying the D362A mutation, resulting in a dominant-negative protein. This mutation is in a conserved calcium binding residue and corresponds to the D307A mutation seen in the orthologous human SYT2 gene in a family with a neuromuscular junction disorder resembling Lambert-Eaton myasthenic syndrome. The protein is tagged with Tag:MYC.